FEATURED COMPANIES
- Acandis
- DePuy Synthes
- Medtronic
- MicroPort Scientific
- phenox
- Stryker
- MORE
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
About Intracranial Stents
Intracranial stents are used for the treatment of atherosclerosis in the carotid or intracranial arteries. Stents are permanent implants that open the blocked arteries, allowing increased blood flow to the brain.
The analysts forecast the global intracranial stents market to grow at a CAGR of 14.85% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global intracranial stents market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Key vendors
Intracranial stents are used for the treatment of atherosclerosis in the carotid or intracranial arteries. Stents are permanent implants that open the blocked arteries, allowing increased blood flow to the brain.
The analysts forecast the global intracranial stents market to grow at a CAGR of 14.85% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global intracranial stents market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Key vendors
- Acandis
- phenox
- Medtronic
- MicroPort Scientific
- DePuy Synthes
- Growing prevalence of aneurysms and related disorders
- For a full, detailed list, view the full report
- High cost associated with stenting procedures
- For a full, detailed list, view the full report
- Growing emergence of dual characteristics intracranial stents
- For a full, detailed list, view the full report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Acandis
- DePuy Synthes
- Medtronic
- MicroPort Scientific
- phenox
- Stryker
- MORE
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
PART 09: MARKET SEGMENTATION BY END-USER
PART 12: DRIVERS AND CHALLENGES
Exhibit 01: Parent market
Exhibit 02: Global neurovascular stents market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Intracranial stents - Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global intracranial stents market - Year over year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Product - Market share 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Self-expanding intracranial stents - Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Self-expanding intracranial stents - Year-over-year growth 2018-2022 (%)
Exhibit 22: Embolization coil support intracranial stents - Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Embolization coil support intracranial stents - Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Global intracranial stents market: Segmentation by end-users 2017
Exhibit 27: Global - Market share by geography 2017-2022 (%)
Exhibit 28: Regional comparison
Exhibit 29: Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 30: Americas - Year-over-year growth 2018-2022 (%)
Exhibit 31: Top three countries in Americas
Exhibit 32: EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 33: EMEA - Year over year growth 2018-2022 (%)
Exhibit 34: Top three countries in EMEA
Exhibit 35: APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 36: APAC - Year over year growth 2018-2022 (%)
Exhibit 37: Top three countries in APAC
Exhibit 38: Market opportunity
Exhibit 39: New product launches 2015-2017
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Global intracranial stents market: Distribution structure
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Acandis overview
Exhibit 47: Acandis -Product category
Exhibit 48: Acandis - Organizational developments
Exhibit 49: Acandis - Geographic focus
Exhibit 50: Acandis - Segment focus
Exhibit 51: Acandis - Key offerings
Exhibit 52: Acandis - Key customers
Exhibit 53: Medtronic: Overview
Exhibit 54: Medtronic: Business segments
Exhibit 55: Medtronic: Organizational developments
Exhibit 56: Medtronic: Geographic focus
Exhibit 57: Medtronic: Segment focus
Exhibit 58: Medtronic: Key offerings
Exhibit 59: Medtronic: Key customers
Exhibit 60: MicroPort Scientific overview
Exhibit 61: MicroPort Scientific - Business segments
Exhibit 62: MicroPort Scientific - Organizational developments
Exhibit 63: MicroPort Scientific - Geographic focus
Exhibit 64: MicroPort Scientific - Segment focus
Exhibit 65: MicroPort Scientific - Key offerings
Exhibit 66: MicroPort Scientific - Key customers
Exhibit 67: phenox overview
Exhibit 68: phenox - Products category
Exhibit 69: phenox - Organizational developments
Exhibit 70: phenox - Geographic focus
Exhibit 71: phenox - Segment focus
Exhibit 72: phenox - Key offerings
Exhibit 73: phenox - Key customers
Exhibit 74: Stryker overview
Exhibit 75: Stryker: Business segments
Exhibit 76: Stryker: Organizational developments
Exhibit 77: Stryker: Geographic focus
Exhibit 78: Stryker: Segment focu
Exhibit 79: Stryker: Key offerings
Exhibit 80: Stryker: Key customers
Exhibit 81: DePuy Synthes: Overview
Exhibit 82: DePuy Synthes: Business areas
Exhibit 83: DePuy Synthes: Organizational developments
Exhibit 84: DePuy Synthes: Geographic focus
Exhibit 85: DePuy Synthes: Segment focus
Exhibit 86: DePuy Synthes: Key offerings
Exhibit 87: DePuy Synthes: Key customers
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Overview
- Comparison by product
- Self-expanding intracranial stents
- Embolization coil support intracranial stents
- Market opportunity by product
PART 09: MARKET SEGMENTATION BY END-USER
- Segmentation by end-user
- Hospitals
- ASCs
- Geographical segmentation
- Regional comparison
- Americas - Market size and forecast 2017-2022
- EMEA - Market size and forecast 2017-2022
- APAC - Market size and forecast 2017-2022
- Market opportunity
PART 12: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
- Growing emergence of dual characteristics intracranial stents
- Increasing product launches and R&D activities
- Overview
- Landscape disruption
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Acandis
- Medtronic
- MicroPort Scientific
- phenox
- Stryker
- DePuy Synthes
- List of abbreviations
Exhibit 01: Parent market
Exhibit 02: Global neurovascular stents market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Intracranial stents - Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global intracranial stents market - Year over year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Product - Market share 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Self-expanding intracranial stents - Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Self-expanding intracranial stents - Year-over-year growth 2018-2022 (%)
Exhibit 22: Embolization coil support intracranial stents - Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Embolization coil support intracranial stents - Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Global intracranial stents market: Segmentation by end-users 2017
Exhibit 27: Global - Market share by geography 2017-2022 (%)
Exhibit 28: Regional comparison
Exhibit 29: Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 30: Americas - Year-over-year growth 2018-2022 (%)
Exhibit 31: Top three countries in Americas
Exhibit 32: EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 33: EMEA - Year over year growth 2018-2022 (%)
Exhibit 34: Top three countries in EMEA
Exhibit 35: APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 36: APAC - Year over year growth 2018-2022 (%)
Exhibit 37: Top three countries in APAC
Exhibit 38: Market opportunity
Exhibit 39: New product launches 2015-2017
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Global intracranial stents market: Distribution structure
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Acandis overview
Exhibit 47: Acandis -Product category
Exhibit 48: Acandis - Organizational developments
Exhibit 49: Acandis - Geographic focus
Exhibit 50: Acandis - Segment focus
Exhibit 51: Acandis - Key offerings
Exhibit 52: Acandis - Key customers
Exhibit 53: Medtronic: Overview
Exhibit 54: Medtronic: Business segments
Exhibit 55: Medtronic: Organizational developments
Exhibit 56: Medtronic: Geographic focus
Exhibit 57: Medtronic: Segment focus
Exhibit 58: Medtronic: Key offerings
Exhibit 59: Medtronic: Key customers
Exhibit 60: MicroPort Scientific overview
Exhibit 61: MicroPort Scientific - Business segments
Exhibit 62: MicroPort Scientific - Organizational developments
Exhibit 63: MicroPort Scientific - Geographic focus
Exhibit 64: MicroPort Scientific - Segment focus
Exhibit 65: MicroPort Scientific - Key offerings
Exhibit 66: MicroPort Scientific - Key customers
Exhibit 67: phenox overview
Exhibit 68: phenox - Products category
Exhibit 69: phenox - Organizational developments
Exhibit 70: phenox - Geographic focus
Exhibit 71: phenox - Segment focus
Exhibit 72: phenox - Key offerings
Exhibit 73: phenox - Key customers
Exhibit 74: Stryker overview
Exhibit 75: Stryker: Business segments
Exhibit 76: Stryker: Organizational developments
Exhibit 77: Stryker: Geographic focus
Exhibit 78: Stryker: Segment focu
Exhibit 79: Stryker: Key offerings
Exhibit 80: Stryker: Key customers
Exhibit 81: DePuy Synthes: Overview
Exhibit 82: DePuy Synthes: Business areas
Exhibit 83: DePuy Synthes: Organizational developments
Exhibit 84: DePuy Synthes: Geographic focus
Exhibit 85: DePuy Synthes: Segment focus
Exhibit 86: DePuy Synthes: Key offerings
Exhibit 87: DePuy Synthes: Key customers
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Acandis
- DePuy Synthes
- Medtronic
- MicroPort Scientific
- phenox
- Stryker
- MORE
New Report Released:-Global Intracranial Stents Market 2018-2022
The author of the report recognizes the following companies as the key players in the global intracranial stents market: Acandis, Phenox, Medtronic, MicroPort Scientific, and DePuy Synthes.
Commenting on the report, an analyst from the research team said: “One trend in the market is growing emergence of dual characteristics intracranial stents. The global intracranial stents market is concentrated with a few prominent vendors that hold the majority market share. To remain competitive in the global market, key vendors are focusing on the introduction of innovative technology for better clinical outcomes.”
According to the report, one driver in the market is growing prevalence of aneurysms and related disorders. The high prevalence of brain aneurysms and cerebral disorders is the major contributor to the growth of the global intracranial stents market. Brain aneurysms and other common neurological disorders are encountered by 2%-6% people globally, which has a positive impact on the growth of this market.
Further, the report states that one challenge in the market is high cost associated with stenting procedures. Intracranial stent placement has been successfully evaluated as a new method of treatment for symptomatic intracranial stenosis in selected patients. The FDA has also approved intracranial stent treatment for symptomatic atherosclerotic intracranial lesions.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
The author of the report recognizes the following companies as the key players in the global intracranial stents market: Acandis, Phenox, Medtronic, MicroPort Scientific, and DePuy Synthes.
Commenting on the report, an analyst from the research team said: “One trend in the market is growing emergence of dual characteristics intracranial stents. The global intracranial stents market is concentrated with a few prominent vendors that hold the majority market share. To remain competitive in the global market, key vendors are focusing on the introduction of innovative technology for better clinical outcomes.”
According to the report, one driver in the market is growing prevalence of aneurysms and related disorders. The high prevalence of brain aneurysms and cerebral disorders is the major contributor to the growth of the global intracranial stents market. Brain aneurysms and other common neurological disorders are encountered by 2%-6% people globally, which has a positive impact on the growth of this market.
Further, the report states that one challenge in the market is high cost associated with stenting procedures. Intracranial stent placement has been successfully evaluated as a new method of treatment for symptomatic intracranial stenosis in selected patients. The FDA has also approved intracranial stent treatment for symptomatic atherosclerotic intracranial lesions.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
- Acandis
- Medtronic
- MicroPort Scientific
- phenox
- Stryker
- DePuy Synthes
Note: Product cover images may vary from those shown
LOADING...
